Literature DB >> 34183730

Exploring the chemical space of protein-protein interaction inhibitors through machine learning.

Jiwon Choi1,2, Jun Seop Yun3, Hyeeun Song3, Nam Hee Kim3, Hyun Sil Kim3, Jong In Yook4,5.   

Abstract

Although protein-protein interactions (PPIs) have emerged as the basis of potential new therapeutic approaches, targeting intracellular PPIs with small molecule inhibitors is conventionally considered highly challenging. Driven by increasing research efforts, success rates have increased significantly in recent years. In this study, we analyze the physicochemical properties of 9351 non-redundant inhibitors present in the iPPI-DB and TIMBAL databases to define a computational model for active compounds acting against PPI targets. Principle component analysis (PCA) and k-means clustering were used to identify plausible PPI targets in regions of interest in the active group in the chemical space between active and inactive iPPI compounds. Notably, the uniquely defined active group exhibited distinct differences in activity compared with other active compounds. These results demonstrate that active compounds with regions of interest in the chemical space may be expected to provide insights into potential PPI inhibitors for particular protein targets.

Entities:  

Year:  2021        PMID: 34183730     DOI: 10.1038/s41598-021-92825-5

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  1 in total

Review 1.  Protein-protein interaction networks (PPI) and complex diseases.

Authors:  Nahid Safari-Alighiarloo; Mohammad Taghizadeh; Mostafa Rezaei-Tavirani; Bahram Goliaei; Ali Asghar Peyvandi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2014
  1 in total
  4 in total

1.  In Silico Prediction of Plasmodium falciparum Cytoadherence Inhibitors That Disrupt Interaction between gC1qR-DBLβ12 Complex.

Authors:  Abdul Hafiz; Rowaida Bakri; Mohammad Alsaad; Obadah M Fetni; Lojain I Alsubaihi; Hina Shamshad
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-31

2.  IFI44 is an immune evasion biomarker for SARS-CoV-2 and Staphylococcus aureus infection in patients with RA.

Authors:  Qingcong Zheng; Du Wang; Rongjie Lin; Qi Lv; Wanming Wang
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786

Review 3.  Aurora A and AKT Kinase Signaling Associated with Primary Cilia.

Authors:  Yuhei Nishimura; Daishi Yamakawa; Takashi Shiromizu; Masaki Inagaki
Journal:  Cells       Date:  2021-12-20       Impact factor: 6.600

4.  A Selective Inhibitor of Cardiac Troponin I Phosphorylation by Delta Protein Kinase C (δPKC) as a Treatment for Ischemia-Reperfusion Injury.

Authors:  Nir Qvit; Amanda J Lin; Aly Elezaby; Nicolai P Ostberg; Juliane C Campos; Julio C B Ferreira; Daria Mochly-Rosen
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.